Crossmark

Perspectives in the treatment of antibiotic-resistant bacterial infections with active photodynamic partners within the framework of the EURESTOP COST Action (CA21145)

Crossref DOI link: https://doi.org/10.1007/s43630-024-00555-0

Published Online: 2024-03-28

Published Print: 2024-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Mori, Mattia https://orcid.org/0000-0003-2398-1254
Dumoulin, Fabienne https://orcid.org/0000-0002-0388-8338
Faustino, M. Amparo F. https://orcid.org/0000-0003-4423-3802
Plaetzer, Kristjan https://orcid.org/0000-0003-1593-6672
Funding

Funding for this research was provided by:

Università degli Studi di Siena
License Information

Text and Data Mining valid from 2024-03-28

Version of Record valid from 2024-03-28
More Information

Article History

Received: 7 November 2023

Accepted: 20 February 2024

First Online: 28 March 2024

Declarations

:

: MM is the chair of the EURESTOP COST Action. KP is the co-editor-in-chief of Photochem. Photobiol. Sci. MAFF, FD, and KP are the co-editors of the Topical issue “Antimicrobial PDT in a One Health World”.

Document is current

Any future updates will be listed below